Keywords: CK; cytokeratins; BC; breast cancer; HER-2; human epidermal growth factor receptor-2; RT-PCR; reverse transcription followed by polymerase chain reaction; BBD; benign breast diseases; TNM; Classification of Malignant Tumors; ER; estrogen receptor; SBR; Sc
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Breast cancer; Lumpectomy; Margins; Elderly women; Geriatrics; 95% CI; 95% confidence interval; ASA; American Society of Anesthesiologists; DFS; disease free survival; ER; estrogen receptor; HR; hazard ratio; IQR; interquartile range; LN; lymph node; LVI;
Keywords: metastatic breast cancer; MBC; lobaplatin and gemcitabine; GL; lobaplatin and vinorelbine; NL; cisplatin and gemcitabine; GP; cisplatin and vinorelbine; NP; progression-free survival; PFS; overall survival; OS; response rate; RR; platinum-based compounds;
Keywords: Adipocyte; Breast cancer; Tumor-stroma interaction; CAF; cancer-associated fibroblast; WAT; white adipose tissue; CLS; crown-like structure; CAA; cancer-associated adipocyte; ECM; extracellular matrix; IL; interleukin; ER; estrogen receptor; TNBC; triple-
Keywords: Krüppel-like factor 4; Meta-analysis; Prognosis; Cancer; Tumor; Carcinoma; TNBC; triple-negative breast cancer; BC; breast cancer; CRC; colorectal cancer; ESCC; esophageal squamous cell carcinoma; GC; gastric cancer; HCC; hepatocellular carcinoma; NPC; n
Keywords: APC; antigen presenting cell; APOBEC; apolipoprotein B mRNA editing enzyme catalytic polypeptide-like; BRCA1/2; breast cancer 1/2; BCSS; breast cancer specific survival; B2M; β-2-microglobulin; CAF; cancer associated fibroblast; CCL; chemokine ligand; CD
Keywords: Adipose tissue; Cancer associated adipocytes; FABP4; FABP5; Lipid metabolism; ADF; adipocyte-derived fibroblasts; BAT; brown adipose tissue; BMAT; bone marrow adipose tissue; BMI; body mass index; CAA; cancer-associated adipocytes; CAF; cancer-associated
Keywords: AI; aromatase inhibitor; ASCO; American Society of Clinical Oncology; CDK4/6; cyclin-dependent kinase 4/6; DCIS; ductal carcinoma in situ; DFS; disease-free survival; ER; estrogen receptor; FDA; Food and Drug Administration; HER2; human epidermal growth f
Keywords: Breast cancer; ER+; HER+; India; PR+; TNBC;
Keywords: ARV-825 PubChem CID 92044400; BETd-246 PubChem CID 131698640; dBET1 PubChem CID 91799313; I-BET151 PubChem CID 52912189; I-BET762 PubChem CID 46943432; JQ1 PubChem CID 46907787; MS417 PubChem CID 59190723; OTX015 PubChem CID 9936746; THZ1 PubChem CID 7360
Keywords: Population-based; Screening; Survival; TNBC;
Keywords: CPM; contralateral prophylactic mastectomy; TNBC; triple-negative breast cancer; VUS; variant of uncertain significance;
Keywords: Breast cancer; Cannabidiol; Apoptosis; mTOR; Cyclin D1 and PPARγ; CBD; Cannabidiol; ER; Estrogen receptor; PR; Progesterone receptor; HER2; Human Epidermal Growth Factor Two; TNBC; Triple Negative Breast Cancer; IP; Immunoprecipitation; MTT; Methylthiazo
Keywords: Cx(s); Connexin(s); CT; Carboxyl tail; DMBA; 7,12-Dimethylbenz(a) anthracene; GJIC; Gap junctional intercellular communication; NO; Nitric oxide; TNBC; Triple-negative breast cancer; Cancer; Gap junction; Connexin; Tumor progression; Cell migration; Invas
Keywords: MG; Mammography; US; Ultrasound; MRI; Magnetic Resonance Imaging; BI-RADS; Breast Imaging Reporting and Data System; BC; Breast Cancer; BRCA; Breast CAncer Antigen; CC; Cranio-Caudal; MLO; Medio-Lateral-Oblique; TNBC; Triple-Negative Breast Cancer; DCIS;
Keywords: MS; mass-spectrometry; NMR; nuclear magnetic resonance spectroscopy; MRS; magnetic resonance spectroscopy; D-2-HG; D-2-hydroxyglutarate; α-KG; α-ketoglutarate; OAA; oxaloacetic acid; TET; ten-eleven translocation; GSH; glutathione; ROS; reactive oxygen
Keywords: ACC; acetyl-CoA carboxylase; ALDOA; aldolase A; AIs; aromatase inhibitors; AMPK; AMP-activated protein kinase; BC; breast cancer; CML; chronic myelogenous leukemia; CT; computed tomography; CPT1; carnitine palmitoyltransferase 1; CRC; colorectal cancer; 2
Keywords: 27-HC; 27-Hydroxycholesterol; 3PO; 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one; ABCG1; ATP-binding cassette subfamily G1; ACBA1; ATP-binding cassette subfamily A1; ACC1; Acetyl-Co-A carboxylase-1; AKAP4; A-kinase anchoring protein 4; ALDO; Aldolase; AM
Keywords: ALK1; activin receptor-like kinase1; ANG/Ang; angiopoietin; Bcl-xL; b-cell lymphoma-extra large; BM; bone marrow; BMDCs; bone marrow derived cells; BMP; bone morphogenetic protein; Bv8; bombina variagata peptide 8; CAFs; cancer/carcinoma associated fibrob
Keywords: BC; breast cancer; NAC; neoadjuvant chemotherapy; HER2; human epidermal growth factor 2; ER; oestrogen receptor; PR; progesterone receptor; TNBC; triple negative breast cancer; PET/CT; positron emission tomography computed tomography; pCR; pathologic comp
Keywords: TME; tumour microenvironment; PD-1; programmed cell death 1; PD-L1; programmed death ligand 1; PD-L2; programmed death ligand 2; PTMs; post-translational histone modifications; DNMTi; DNA methyltransferase inhibitor; HDACi; histone deacetylase inhibitor;
Keywords: Optical mammography; near-infrared spectroscopy; breast cancer; neoadjuvant therapy; [Hb]; concentration of deoxyhemoglobin; [HbO2]; concentration of oxyhemoglobin; [HbT]; concentration of total hemoglobin; CRI; cumulative response index; Hgb; hemoglobin
27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer
Keywords: 27-OHC; 27-hydroxycholesterol; ADT; androgen deprivation therapy; AR; androgen receptor; ATF4; Activating Transcription Factor 4; ATF6; Activating Transcription Factor 6; C/EBP; CCAAT / Enhancer binding proteins; CHOP; C/EBP homologous protein; CIP2A; can
Keywords: Discontinuation; Disparities; Noninitiation; Race; TNBC;
Keywords: TNBC; triple negative breast cancer; ER; estrogen receptor; PR; progesterone receptor; BMI; Body mass index; IDC; Infiltrating Duct Carcinoma; ng/mL; nanogram per millilitre; μg/ml; microgram per millilitre; Triple negative breast cancer; Leptin; Adipone
Keywords: TNBC; triple negative breast cancer; ROS; reactive oxygen species; H2DCFDA; 2â²,7â²-dichlorodihydrofluorescein diacetate; MTT; 3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tetrazolium bromide; CI value; combination index value; DXR; doxorubicin; 3-MA; 3
Keywords: BC; breast cancer; ER; oestrogen receptor; IDC; invasive ductal breast cancer; IHC; immunohistochemistry; GG; Genomic Grade; ILC; invasive lobular breast cancer; LOH; loss of heterozygosity; PR; progesterone receptor; RATHER; Rational Therapy for Breast C
Keywords: ETC; electron transport complexes; ROS/RNS; reactive oxygen or nitrogen spices; âÏm; mitochondrial inner membrane potential; TCA; TriCarboxylic acid cycle; MPTP; mitochondrial permeability transition pore; mtDNA; mitochondrial DNA; ND5; NADH dehydrogen
Keywords: ACL; ATP citrate lyase; Akt; Protein kinase B; ASCT2; Alanine, serine, cysteine-preferring transporter 2; ASS; Argininosuccinate synthetase; BMI; Body mass index; CAF; Cancer-associated fibroblasts; ER; Estrogen receptor; FASN; Fatty acid synthase; GPC; G
Metal complexes of tridentate tripod ligands in medical imaging and therapy
Keywords: 2-TicNMe; tris(N-methylimidazol-2-yl)carbonil; 2-TipiPr2; tris(1,4-diisopropylimidazol-2-yl)phosphane; 4-TipH; tris(imidazole-4-yl)phosphane; AO; acridine orange; BBB; blood brain barrier; BBN; bombesin; bdmpza; 3,3-bis(3,5-dimethylpyrazol-1-yl)acetate; b
Keywords: ADT; androgen deprivation therapy; AR; androgen receptor; ASO; antisense oligonucleotide; CARN; castration-resistant Nkx3.1 expressing cells; CK; cytokeratin; CRPC; castration-resistant prostate cancer; DMBA; 7,12-dimethylbenz[a]anthracene; ECM; extracell
Keywords: Sphingosine-1-phosphate; Sphingosine kinase; Estradiol; Breast cancer; FTY720/Fingolimod; ERα; estrogen receptor α; EGFR; epidermal growth factor receptor; ERE; estrogen response element; ERK; extracellular signal regulated kinase; E2; 17β-estradiol; H
Keywords: Unfolded protein response; Myeloid cells; T cells; Inflammation; Cell-nonautonomous; Tumor microenvironment; APC; antigen presenting cells; ATF6; activating transcription factor 6; CHOP; CCAAT/-enhancer binding protein homologous protein; DC; dendritic ce
Keywords: Dicer; Breast cancer; Estrogen receptor; TNBC; Immunohistochemistry
Keywords: Deoxyelephantopin; DET derivatives; Triple-negative breast cancer; Lung metastasis; Paclitaxel; DEAD; diethyl azodicarboxylate; DET; deoxyelephantopin; DETD; deoxyelephantopin derivative; DMAP; dimethylaminopyridine; EDCI; 1-(3-dimethylaminopropyl)-3-ethy
Keywords: Ab; Antibody; ABC; ATP-binding cassette; AIOM; Associazione Italiana di Oncologia Medica; ALCAM; Activated leukocyte cell adhesion molecule; APOD; Apolipoprotein D; AR; androgen receptor; AURKA; Aurora kinase A; AURKB; Aurora kinase B; BCS; Biopharmaceuti
Keywords: Breast cancer; Young age; Triple-negative subtype; BRCA mutation; ACOSOG; American college of surgeons oncology group; BCSS; breast cancer-specific survival; BCT; breast-conserving therapy; CI; confidence interval; CBC; contralateral breast cancer; CPM; c
Keywords: Chemotherapy; TNBCtype; Neoadjuvant; PIK3CA; Androgen receptor; TNBC; triple negative breast cancer; pCR; pathological complete response; HR; homologous recombination; EMT; epithelial-mesenchymal-transition; AR; androgen receptor; TILs; tumor-infiltrati
Keywords: ERK; extracellular signal-regulated kinase; EGFR; epidermal growth factor receptor; ELISA; enzyme-linked immunosorbent assay; FFPE; formalin-fixed paraffin-embedded; FISH; fluorescence in situ hybridization; FNA; fine-needle aspiration; F/RPPA; forward/re
Keywords: ALA; α-linolenic acid; BC; breast cancer; DHA; docosahexaenoic acid; E2; 17-β estradiol; EPA; eicosapentaenoic acid; ER; estrogen receptor; HER2; human epidermal growth factor receptor 2; n-3 PUFA; omega-3 polyunsaturated fatty acid; PR; progesterone re
Keywords: Doxorubicin; Ovatodiolide; TNBC; Breast cancer; Drug toxicity; Cancer stem cell;
Keywords: BBB; blood-brain barrier; BRCA; breast cancer associated; ER; estrogen receptor; CTC; circulating tumor cell; ctDNA; circulating tumor DNA; DRFI; distant recurrence-free interval; DTC; disseminated tumor cell; EMT; epithelial-to-mesenchymal transition;
Keywords: Breast cancer; HER-2-negative; Resistance; Biologic targeted agent; Combination therapy; ABC; advanced breast cancer; AE; adverse event; AI; aromatase inhibitor; AKT; protein kinase; BC; breast cancer; CDK; cyclin-dependent kinase; CT; chemotherapy; CTLA;
Keywords: Breast cancer; Immune system; Biomarkers; Immunotherapies; Immune checkpoint blockade; Tumor vaccines; ADCC; antibody dependent cellular cytotoxicity; BiTES; bispecific single chain monoclonal antibodies; CAR; T cells engineered to express artificial chim
Keywords: lncRNA; long/large noncoding RNA; Xist; X-inactive specific transcript; mESC; mouse embryonic stem cell; Evf2; embryonic ventral forebrain 2; Six3os; sine oculis-related homeobox 3 homolog, opposite strand; Dlx1as; distal-less homeobox 1, antisense; EGO;
Keywords: TNBC; Androgen receptor; Steroid metabolism;
I-7ab inhibited the growth of TNBC cells via targeting HDAC3 and promoting the acetylation of p53
Keywords: TNBC; I-7ab; HDAC3; p53; Cell cycle arrest; Cell apoptosis;
Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p
Keywords: TNBC; GAS5; Metastasis; Progression; miR-196a-5p; FOXO1;
SRT1720, a potential sensitizer for radiotherapy and cytotoxicity effects of NVB-BEZ235 in metastatic breast cancer cells
Keywords: TNBC; triple negative breast cancer; IL-6; interleukin 6; BC; breast cancer; PI3K; phosphatidylinositol 3-kinase; mTOR; Mammalian target of rapamycin; CSC; cancer stem cell; CRT; chemo-radio therapy; Breast cancer; Chemo-radiotherapy; Cancer stem cells; I
MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer
Keywords: Breast cancer; miRNA; miRNA cluster; miRNA co-expression; Microarray; BC; breast cancer; DCIS; ductal carcinoma in-situ; ECM; extracellular matrix; EMT; epithelial to mesenchymal transition; ER; estrogen receptor; GSEA; gene set enrichment analysis; IDC;